Tuesday, April 30, 2019
MZ Digital Marketing Agency
from Reuters: Health News https://reut.rs/2UJg6yv
Tuesday, April 30, 2019
Tuesday, April 30, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc's cholesterol drug Praluent as a treatment to cut the risk of heart attacks, stroke and other major cardiovascular events.
from Reuters: Health News https://reut.rs/2UJg6yv
from Reuters: Health News https://reut.rs/2UJg6yv
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment